Drug Target Review – Issue 2 2019

Posted: 5 June 2019 | | No comments yet

In this issue: novel approaches to produce radiolabelled antibodies, the use of CRISPR/Cas9 to accelerate the development of targeted therapies and utilisation of stem cells to study the effects of cannabis on neuronal development.

Included in this issue:

    Radiochemistry and drug synthesis ‘in a flash’
    Professor Dr Jason P. Holland, University of Zurich, Switzerland
    Bringing native analysis into the fast-moving world of biologics
    Christopher Nortcliffe, Applications Specialist, LC/MS Biologics and Biopharma, SCIEX
    Phenotypic profiling in drug discovery
    Sean Lin, Ina Rothenaigner, Kamyar Hadian
    High-content imaging: challenges of the 3D world
    Margaritha M. Mysior and Jeremy C. Simpson, UCD Cell Screening Laboratory, School of Biology & Environmental Science, University College Dublin, Ireland    
    Stem-cell technologies in immunotherapy 
    Aparajita DubeyAssociate Scientific Manager, Biocon Biologics Limited, Bangalore, India

The rest of this content is restricted - login or subscribe free to access

DTR Issue 3 2021 MiniMagThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here